United States Pertussis Vaccine Market Report 2017

October 2017 | 102 pages | ID: U44A0BD7713WEN
QYResearch

Abstracts

In this report, the United States Pertussis Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pertussis Vaccine in these regions, from 2012 to 2022 (forecast).

United States Pertussis Vaccine market competition by top manufacturers/players, with Pertussis Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi Pasteur
• GSK
• Mitsubishi Tanabe Pharma Corporation
• Astellas Pharma
• Minhai Biotechnology
• Wuhan Institute of Biological Products
• Changchun Changsheng Life Sciences
• Beijing Tiantan Biological Products
• Chengdu Institute of Biological Products

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Whole-cell Vaccines
• Acellular Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pertussis Vaccine for each application, including

• Children Application
• Adults Application

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pertussis Vaccine Market Report 2017

1 PERTUSSIS VACCINE OVERVIEW

1.1 Product Overview and Scope of Pertussis Vaccine
1.2 Classification of Pertussis Vaccine by Product Category
  1.2.1 United States Pertussis Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pertussis Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Whole-cell Vaccines
  1.2.4 Acellular Vaccines
1.3 United States Pertussis Vaccine Market by Application/End Users
  1.3.1 United States Pertussis Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Children Application
  1.3.3 Adults Application
1.4 United States Pertussis Vaccine Market by Region
  1.4.1 United States Pertussis Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pertussis Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Pertussis Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pertussis Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Pertussis Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Pertussis Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Pertussis Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pertussis Vaccine (2012-2022)
  1.5.1 United States Pertussis Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Pertussis Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES PERTUSSIS VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pertussis Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pertussis Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pertussis Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Pertussis Vaccine Market Competitive Situation and Trends
  2.4.1 United States Pertussis Vaccine Market Concentration Rate
  2.4.2 United States Pertussis Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pertussis Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PERTUSSIS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pertussis Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Pertussis Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Pertussis Vaccine Price by Region (2012-2017)

4 UNITED STATES PERTUSSIS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pertussis Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pertussis Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Pertussis Vaccine Price by Type (2012-2017)
4.4 United States Pertussis Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PERTUSSIS VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pertussis Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Pertussis Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PERTUSSIS VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi Pasteur
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pertussis Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.2 Pertussis Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Mitsubishi Tanabe Pharma Corporation
  6.3.2 Pertussis Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Astellas Pharma
  6.4.2 Pertussis Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Astellas Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Minhai Biotechnology
  6.5.2 Pertussis Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Wuhan Institute of Biological Products
  6.6.2 Pertussis Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Changchun Changsheng Life Sciences
  6.7.2 Pertussis Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Beijing Tiantan Biological Products
  6.8.2 Pertussis Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Beijing Tiantan Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Chengdu Institute of Biological Products
  6.9.2 Pertussis Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 PERTUSSIS VACCINE MANUFACTURING COST ANALYSIS

7.1 Pertussis Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pertussis Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pertussis Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pertussis Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PERTUSSIS VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pertussis Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pertussis Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Pertussis Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Pertussis Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pertussis Vaccine
Figure United States Pertussis Vaccine Market Size (10 K Doses) by Type (2012-2022)
Figure United States Pertussis Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Whole-cell Vaccines Product Picture
Figure Acellular Vaccines Product Picture
Figure United States Pertussis Vaccine Market Size (10 K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Pertussis Vaccine by Application in 2016
Figure Children Application Examples
Table Key Downstream Customer in Children Application
Figure Adults Application Examples
Table Key Downstream Customer in Adults Application
Figure United States Pertussis Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2022)
Figure United States Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pertussis Vaccine Market Major Players Product Sales Volume (10 K Doses) (2012-2017)
Table United States Pertussis Vaccine Sales (10 K Doses) of Key Players/Suppliers (2012-2017)
Table United States Pertussis Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pertussis Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Pertussis Vaccine Sales Share by Players/Suppliers
Figure United States Pertussis Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pertussis Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pertussis Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pertussis Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Pertussis Vaccine Revenue Share by Players/Suppliers
Table United States Market Pertussis Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Pertussis Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Pertussis Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Pertussis Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pertussis Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pertussis Vaccine Product Category
Table United States Pertussis Vaccine Sales (10 K Doses) by Region (2012-2017)
Table United States Pertussis Vaccine Sales Share by Region (2012-2017)
Figure United States Pertussis Vaccine Sales Share by Region (2012-2017)
Figure United States Pertussis Vaccine Sales Market Share by Region in 2016
Table United States Pertussis Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pertussis Vaccine Revenue Share by Region (2012-2017)
Figure United States Pertussis Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Pertussis Vaccine Revenue Market Share by Region in 2016
Table United States Pertussis Vaccine Price (USD/Dose) by Region (2012-2017)
Table United States Pertussis Vaccine Sales (10 K Doses) by Type (2012-2017)
Table United States Pertussis Vaccine Sales Share by Type (2012-2017)
Figure United States Pertussis Vaccine Sales Share by Type (2012-2017)
Figure United States Pertussis Vaccine Sales Market Share by Type in 2016
Table United States Pertussis Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pertussis Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pertussis Vaccine by Type (2012-2017)
Figure Revenue Market Share of Pertussis Vaccine by Type in 2016
Table United States Pertussis Vaccine Price (USD/Dose) by Types (2012-2017)
Figure United States Pertussis Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Pertussis Vaccine Sales (10 K Doses) by Application (2012-2017)
Table United States Pertussis Vaccine Sales Market Share by Application (2012-2017)
Figure United States Pertussis Vaccine Sales Market Share by Application (2012-2017)
Figure United States Pertussis Vaccine Sales Market Share by Application in 2016
Table United States Pertussis Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Pertussis Vaccine Sales Growth Rate by Application (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GSK Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure GSK Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation Basic Information List
Table Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Minhai Biotechnology Basic Information List
Table Minhai Biotechnology Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Wuhan Institute of Biological Products Basic Information List
Table Wuhan Institute of Biological Products Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Changchun Changsheng Life Sciences Basic Information List
Table Changchun Changsheng Life Sciences Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Beijing Tiantan Biological Products Basic Information List
Table Beijing Tiantan Biological Products Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Chengdu Institute of Biological Products Basic Information List
Table Chengdu Institute of Biological Products Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Sales Growth Rate (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Sales Market Share in United States (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pertussis Vaccine
Figure Manufacturing Process Analysis of Pertussis Vaccine
Figure Pertussis Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pertussis Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Pertussis Vaccine
Table Distributors/Traders List
Figure United States Pertussis Vaccine Sales Volume (10 K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Pertussis Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pertussis Vaccine Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Pertussis Vaccine Sales Volume (10 K Doses) Forecast by Type (2017-2022)
Figure United States Pertussis Vaccine Sales Volume (10 K Doses) Forecast by Type (2017-2022)
Figure United States Pertussis Vaccine Sales Volume (10 K Doses) Forecast by Type in 2022
Table United States Pertussis Vaccine Sales Volume (10 K Doses) Forecast by Application (2017-2022)
Figure United States Pertussis Vaccine Sales Volume (10 K Doses) Forecast by Application (2017-2022)
Figure United States Pertussis Vaccine Sales Volume (10 K Doses) Forecast by Application in 2022
Table United States Pertussis Vaccine Sales Volume (10 K Doses) Forecast by Region (2017-2022)
Table United States Pertussis Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pertussis Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pertussis Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources